CAS 175481-26-2

Propanamide, 2-(acetylamino)-3-methoxy-N-(phenylmethyl)-

Description:

Propanamide, 2-(acetylamino)-3-methoxy-N-(phenylmethyl)-, also known by its CAS number 175481-26-2, is an organic compound characterized by its amide functional group, which is derived from propanoic acid. This compound features a methoxy group (-OCH3) and an acetylamino group (-C(=O)NH-CH3) attached to the propanamide backbone, contributing to its unique chemical properties. The presence of the phenylmethyl group (benzyl group) enhances its lipophilicity, potentially influencing its solubility and biological activity. The structure suggests that it may exhibit various interactions, including hydrogen bonding and hydrophobic interactions, which can affect its reactivity and stability. This compound may be of interest in pharmaceutical research due to its potential biological activities, although specific applications and effects would depend on further empirical studies. As with many organic compounds, safety and handling precautions should be observed, particularly in laboratory settings.

Formula: C₁₃H₁₈N₂O₃

InChI: InChI=1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)

InChI key: InChIKey=VPPJLAIAVCUEMN-UHFFFAOYSA-N

SMILES: C(NC(C(NC(C)=O)COC)=O)C1=CC=CC=C1

Synonyms:

• 2-(Acetylamino)-3-methoxy-N-(phenylmethyl)propanamide
• 2-Acetamido-N-benzyl-3-methoxypropanamide
• Propanamide, 2-(acetylamino)-3-methoxy-N-(phenylmethyl)-
• rac-Lacosamide-d3
• VIMPAT RACEMATE; ERLOSAMIDE RACEMATE
• Vimpat racemate
• Lacosamide racemate
• Erlosamide racemate

rac-Lacosamide-d3

CAS: 175481-26-2

Formula: C₁₃H₁₅D₃N₂O₃

Color and Shape: White To Off-White Solid

Molecular weight: 253.32

Ref: 4Z-L-282

rac-Lacosamide

CAS: 175481-26-2

Formula: C₁₃H₁₈N₂O₃

Molecular weight: 250.30

Ref: 4Z-L-2857

Lacosamide Racemate

CAS: 175481-26-2

Formula: C₁₃H₁₈N₂O₃

Molecular weight: 250.30

Ref: ST-EA-CP-L8021

Lacosamide (racemate)

Controlled Product

CAS: 175481-26-2

Lacosamide is a drug that is used for the treatment of epilepsy. It has been shown to inhibit neuronal death in vitro and in animal models, and has been extensively studied for its potential benefits in the treatment of bowel disease. The mechanism of action for lacosamide involves inhibition of the transport of neurotransmitters from the synaptic cleft by binding to the neuronal sodium channels and increasing their recovery rate. Lacosamide has also been found to affect energy metabolism by inhibiting the activity of mitochondrial enzymes such as matrix effect and complex I/III.

Formula: C₁₃H₁₈N₂O₃

Purity: Min. 95%

Molecular weight: 250.29 g/mol

Ref: 3D-AHA48126